Family offices fear dollar depreciation, lower investment returns in wake of tariffs

Family offices fear dollar depreciation, lower investment returns in wake of tariffs


Compassionate Eye Foundation/david Oxberry | Digitalvision | Getty Images

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.

Family offices have been investing with more caution since President Donald Trump’s tariff announcement in early April, according to a recent survey released by RBC Wealth Management and research firm Campden Wealth.

In a poll of 141 investment firms of ultra-wealthy families in North America, the majority (52%) of respondents said cash and other liquid assets would offer the best returns over the next 12 months. More than 30% said artificial intelligence would offer the best returns. (Respondents could pick multiple answers). In last year’s survey, growth equities and defense industries were the most popular choices, each tallying just under a third of respondents.

Family offices also lowered their expectations for 2025 returns, reporting an average expected portfolio return of 5% for the year, down from 11% in 2024. Fifteen percent of respondents said they expected negative returns, while nearly none did the year prior. The most popular investment priority for 2025 was improving liquidity, which was selected by nearly half of family offices. Last year’s top choice, at 34%, was portfolio diversification.

The survey was conducted from April through August. RBC Wealth Management’s Bill Ringham said that tariff-induced market turmoil and geopolitical tensions played a “pivotal role” in the pessimistic poll results.

While U.S. markets have rebounded to record highs since the spring, family offices still have other reasons to be bearish. A whopping 52% of respondents cited depreciation of the U.S. dollar as a likely market risk. The dollar has dropped by nearly 9% since the beginning of the year, and banks including UBS expect depreciation to continue.

The slowdown in exits for private equity and venture capital, a common complaint from family offices per the report, continues to drag on. Nearly a quarter of respondents said private equity funds have not met their expected investment returns for 2025, and 15% said the same of private equity direct investments. Venture capital scored the lowest net sentiment, with 33% reporting unsatisfactory returns.

That said, family offices are flocking to cash not only to mitigate risk but also to make opportunistic bets in the future, Ringham said.

“They’re taking a much longer vision of their legacy and their family,” said Ringham, who directs private wealth strategies for the bank’s U.S. arm. “By doing this, they’re probably creating the capital to take advantage of opportunities as they see them coming through in the market.”

Get Inside Wealth directly to your inbox

This cautious optimism can be seen in the respondents’ intended asset allocation changes, he said. Only a net 3% of family offices plan to increase their allocation to cash and liquid assets, compared to 20% for direct private equity investments and 13% for private equity funds.

Investing in private markets is a necessity to create enough wealth to beat inflation and accommodate a growing family, Ringham said.

“When family offices are putting together portfolios, they’re obviously looking at time horizons that can last much longer than individuals that don’t have this type of legacy wealth. I mean, we’re looking at 100 years to 100 years plus,” he said. “If you’re taking the long view, even though you might realize that private equity hasn’t been performing that well over the past couple years, it’s still a place where historical returns might have exceeded returns that you might find elsewhere.”



Source

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
Business

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from […]

Read More
Major League Baseball names Polymarket exclusive prediction market partner
Business

Major League Baseball names Polymarket exclusive prediction market partner

Shayne Coplan, chief executive officer of Polymarket, on the floor of the New York Stock Exchange (NYSE) in New York, US, on Thursday, Nov. 13, 2025. Michael Nagle | Bloomberg | Getty Images Major League Baseball on Thursday announced it was naming Polymarket its official prediction market partner. The association also signed a memorandum of […]

Read More
Real estate could be the big winner in the private credit exodus
Business

Real estate could be the big winner in the private credit exodus

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Barely […]

Read More